What is Castle Biosciences's change in accrued liabilities?

Castle Biosciences (CSTL) reported change in accrued liabilities of -$19.18M in Q1 2026.

How has Castle Biosciences's change in accrued liabilities changed year-over-year?

Castle Biosciences's change in accrued liabilities decreased by 30.5% year-over-year, from -$14.7M to -$19.18M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Castle Biosciences CSTL Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Labcorp HoldingsLH

-$27.4M+84.3%

Personalis, Inc.PSNL

-$426K+84.5%

NeoGenomicsNEO

-$7M+69.5%

Fulgent Genetics, Inc.FLGT

-$2.12M+71.6%

Cogent Biosciences, Inc.COGT

-$10.2M-17.8%

BillionToOne, Inc. BLLN

-$331K-136%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's change in accrued liabilities?: Castle Biosciences (CSTL) reported change in accrued liabilities of -$19.18M in Q1 2026.
How has Castle Biosciences's change in accrued liabilities changed year-over-year?: Castle Biosciences's change in accrued liabilities decreased by 30.5% year-over-year, from -$14.7M to -$19.18M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.